(Q35875302)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15338755%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

review article

1 reference

title

Mechanisms of tumor evasion from the immune response (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15338755%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Paulo C Rodríguez

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15338755%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Arnold H Zea

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15338755%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Augusto C Ochoa

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15338755%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15338755%20AND%20SRC:MED&resulttype=core&format=json

Cancer chemotherapy and biological response modifiers

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15338755%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15338755%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

351-364

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15338755%20AND%20SRC:MED&resulttype=core&format=json

In vitro suppression of immunocompetent cells by lymphomas from aging mice

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Impaired in Vitro Lymphocyte Transformation in Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Persistent immunologic abnormalities in long-term survivors of advanced Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Prognostic Value of Host Immunocompetence in Urologic Cancer Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Defective autologous mixed lymphocyte reaction (AMLR) and killer activity generated in the AMLR in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Cellular immune responses to methylcholanthrene-induced fibrosarcoma in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Immunity to murine sarcoma virus induced tumours. IV. Direct cellular cytolysis of 51Cr labelled target cells in vitro and analysis of blocking factors which modulate cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Blocking of cell‐mediated tumor immunity by sera from patients with growing neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Correlation of "sneaking through" of tumor cells with specific immunological impairment of the host

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Specificity of the T Cells That Mediate and Suppress Adoptive Immunotherapy of Established Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Ly-1+2- suppressor T cells inhibit the expression of passively transferred antitumor immunity by suppressing the generation of cytolytic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Diversity of cytokine synthesis and function of mouse CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

The role of Fas/FasL in immunosuppression induced by human tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Suppressive effects of visceral tumor on the generation of antitumor T cells for adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

The roles of IFN gamma in protection against tumor development and cancer immunoediting

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Cancer immunoediting: from immunosurveillance to tumor escape

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Tolerance, danger, and the extended family

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

MHC antigens and tumor escape from immune surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

HLA class I antigen abnormalities and immune escape by malignant cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Identification of human cancers deficient in antigen processing

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Molecular characterization of defective antigen processing in human prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Human leukocyte antigen class I gene mutations in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Locus-specific analysis of human leukocyte antigen class I expression in melanoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

The B7 and CD28 receptor families

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

CD80 expression in an HLA-A2-positive human non-small cell lung cancer cell line enhances tumor-specific cytotoxicity of HLA-A2-positive T cells derived from a normal donor and a patient with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Development of immunogenic colorectal cancer cell lines for vaccination: expression of CD80 (B7.1) is not sufficient to restore impaired primary T cell activation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Comparison of cytokines and CD80 for enhancement of immunogenicity of cervical cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

How melanoma cells evade trail-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Dendritic cells infected with poxviruses encoding MART-1/Melan A sensitize T lymphocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MART1 and gp100

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Immature myeloid cells and cancer-associated immune suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Reciprocal regulation of plasmacytoid dendritic cells and monocytes during viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Regulation of macrophage functions by L-arginine

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Regulation of nitric oxide production by arginine metabolic enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

A T cell receptor transgenic model of severe, spontaneous organ-specific autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Cutting edge: depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Do CD4+ CD25+ immunoregulatory T cells hinder tumor immunotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

The Fas counterattack: cancer as a site of immune privilege

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Impediments to successful immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Molecular cloning of the zeta chain of the T cell antigen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Signal transduction events leading to T-cell lymphokine gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Blocked Ras activation in anergic CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Anergic T-lymphocyte clones have altered inositol phosphate, calcium, and tyrosine kinase signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Gradual loss of T-helper 1 populations in spleen of mice during progressive tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Molecular regulation of cytokine gene expression: interferon-gamma as a model system.

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Variable expression of CD3-zeta and associated protein tyrosine kinases in lymphocytes from patients with myeloid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

High frequency of cancer patients with abnormal assembly of the T cell receptor-CD3 complex in peripheral blood T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Expression of cytokine genes or proteins and signaling molecules in lymphocytes associated with human ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Immunological escape mechanisms in pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

T cells from late tumor-bearing mice express normal levels of p56lck, p59fyn, ZAP-70, and CD3 zeta despite suppressed cytolytic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Correlation between disease activity and T-cell CD3 zeta chain expression in a B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

The decreased expression of CD3 ζ chains in cancer patients is not reversed BY IL-2 Administration

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Restoration of expression of signal-transduction molecules in lymphocytes from patients with metastatic renal cell cancer after combination immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T-cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Protection by L-2-oxothiazolidine-4-carboxylic acid of hydrogen peroxide-induced CD3zeta and CD16zeta chain down-regulation in human peripheral blood lymphocytes and lymphokine-activated killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Renal cell carcinoma-derived gangliosides suppress nuclear factor-kappaB activation in T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Alterations in NFkappaB activation in T lymphocytes of patients with renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Induction of programmed cell death and immunosuppression by exogenous sphingolipids are separate processes

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

Regulation of T cell receptor CD3zeta chain expression by L-arginine

1 reference

https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921018-8

7 January 2021

10.1016/S0921-4410(03)21018-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15338755%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference